Blog Summary
Compounded glutamine acid-resistant capsules are prescription-only preparations designed to resist stomach acid and release farther along the digestive tract. A provider may consider this dosage form when a commercially available product does not meet a patient’s specific strength, capsule, or excipient needs as part of a broader ulcerative colitis care plan.
Â
Key Takeaways
- Acid-resistant capsules are designed to delay release until after leaving the stomach.
- Compounding may allow a provider to request a specific glutamine strength, capsule type, or excipient profile.
- A 2008 study evaluated compounded glutamine capsules as part of a combination ulcerative colitis regimen, not as a standalone therapy.
- Compounded glutamine capsules require a valid prescription and should only be used under the direction of a licensed healthcare provider.
- HDRx pharmacists are available to discuss patient-specific prescription and formulation questions with prescribers.
Â
For prescribers: Healing Dose pharmacists are available to discuss patient-specific strengths, acid-resistant capsule options, and formulation considerations.Â
Compounded Glutamine Capsules for Ulcerative Colitis
Addressing ulcerative colitis (UC) often requires individualized medication planning. Along with selecting the appropriate medication, providers may also consider dosage form, release location, and patient-specific formulation needs.
Why Might a Prescriber Request an Acid-Resistant Compounded Capsule?
An enterosoluble capsule is an acid-resistant dosage form designed to remain intact in the stomach and release its contents farther along the digestive tract.
A licensed prescriber may request a compounded glutamine capsule when an appropriate commercially available option does not meet a patient’s specific prescription needs.
Depending on the prescription, the provider may specify:
- Glutamine strength
- Acid-resistant capsule type
- Capsule material
- Excipient preferences
- Quantity and directions for use
An acid-resistant capsule should not automatically be described as delivering glutamine directly to the colon. The precise release location may depend on the capsule design, formulation, gastrointestinal pH, and transit time.
Compounded drugs are not FDA-approved. FDA does not review compounded preparations for safety, effectiveness, or quality before they are marketed.
What Does the Research Show?
A 2008 clinical study evaluated compound glutamine enterosoluble capsules as part of a broader ulcerative colitis regimen that also included glucocorticoids and retention enema therapy.
The authors reported greater short-term improvement in measures that included bloody stool, abdominal pain, disease activity scores, and the time required for mucous and bloody stool to resolve in the combination-regimen group.
However, glutamine was not evaluated independently. Therefore, the study cannot establish whether glutamine alone caused the reported differences. The study’s design, combination regimen, and limited available evidence should be considered when interpreting the findings.
A separate 2020 preclinical study evaluated glutamine in mice with DSS-induced colitis. The researchers reported changes in oxidative stress markers and intestinal tissue measures, but animal findings do not establish clinical effectiveness in human patients.
Recommended Dosing of Glutamine
Partnering With HDRx for Patient-Specific Formulations
Healing Dose Compounding Pharmacy works with licensed prescribers to prepare patient-specific formulations according to the written prescription.
HDRx pharmacists are available to discuss:
- Requested strengths and capsule options
- Capsule materials and excipient considerations
- Formulation feasibility
- Prescription submission requirements
A pharmacist can provide information about available formulation options but does not replace the prescriber’s clinical judgment regarding whether glutamine is appropriate for a particular patient.
Information for Patients
Compounded glutamine capsules require a prescription from a licensed healthcare provider. HDRx pharmacists can answer questions about how a prescribed preparation is compounded, filled, stored, or shipped.
Questions about ulcerative colitis symptoms, therapy options, medication changes, or whether glutamine may be appropriate should be discussed with a gastroenterologist or other prescribing healthcare provider.
Frequently Asked Questions About Compounded Glutamine Capsules
What is a compounded glutamine acid-resistant capsule?
It is a prescription preparation made when a provider requests glutamine in an acid-resistant capsule with patient-specific formulation details.
What does enterosoluble mean?
Enterosoluble is another term for acid-resistant. It describes a capsule designed to resist dissolution in the stomach and release farther along the digestive tract.
Why might a provider request this dosage form?
A provider may request an acid-resistant capsule when immediate release in the stomach does not align with the intended formulation plan or when a patient requires a specific strength, capsule material, or excipient profile.
Does compounded glutamine require a prescription?
Yes. HDRx prepares compounded glutamine capsules only pursuant to a valid prescription from a licensed healthcare provider.
Is compounded glutamine FDA-approved for ulcerative colitis?
Compounded drugs are not FDA-approved. FDA does not evaluate compounded preparations for safety, effectiveness, or quality before they are marketed. A prescriber must determine whether a compounded preparation is appropriate for an individual patient.
References
- Mayo Clinic. (2025, October 3). Ulcerative colitis: Diagnosis and treatment. Link
- National Institute of Diabetes and Digestive and Kidney Diseases. (2020, September). Ulcerative colitis. Link Â
- Tan, H., Sun, M.-Y., & Yang, J. (2008). [Effect of retention enema with combination of compound glutamine entero-soluble capsule and glucocorticoids for treatment of ulcerative colitis]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 28(7), 645–647. LinkÂ
- Yan, S., Hui, Y., Li, J., Xu, X., Li, Q., & Wei, H. (2020). Glutamine relieves oxidative stress through PI3K/Akt signaling pathway in DSS-induced ulcerative colitis mice. Iranian Journal of Basic Medical Sciences, 23(9), 1124–1129. Link
